| Investments, on behalf of Lilly Endowment Inc10% owner · 4 transactions | — | 110.91Mas of Jan 2021 | — | — | 220.0K |
| Lilly Endowment IncFormer 10% Shareholder · 6623 transactions | — | 91.88M | — | — | 55.64M |
| Lechleiter John Cformer director · 160 transactions | — | 1.86M†as of Dec 2017 | 1.91M | 19.6K | 50.0K |
| Rice Derica WEVP-Global Services and CFO · 88 transactions | — | 848.3K†as of Jan 2018 | 754.2K | — | 126.7K |
| Taurel SidneyChairman, Director · 34 transactions | — | 771.6K†as of Dec 2008 | 407.9K | — | 25.0K |
| Ricks David APresident, Chair, and CEO, Director · 75 transactions | — | 708.8K† | 1.01M | 6.2K | 19.7K |
| Lundberg Jan MEVP,Science&Tech and Pres. LRL · 29 transactions | — | 414.6K†as of Feb 2018 | 470.3K | — | 162.8K |
| Harrington Michael JSenior VP and General Counsel · 31 transactions | — | 280.6K†as of Jan 2020 | 171.1K | — | 38.8K |
| Walsh Fionnuala MSVP, Global Quality · 34 transactions | — | 275.2K†as of Feb 2017 | 157.8K | — | 25.4K |
| Skovronsky DanielEVP, CS&PO & Pres. LRL · 30 transactions | — | 235.7K† | 209.7K | 16.0K | 5.0K |
| Santini GinoSr.VP, Corp. Strategy & BD · 46 transactions | — | 210.4K†as of Feb 2010 | 62.9K | — | — |
| Golden Charles EExec. Vice President and CFO, Director · 14 transactions | — | 177.8K†as of May 2006 | 48.9K | — | 21.2K |
| Fry Stephen FSVP, HR & Diversity · 48 transactions | — | 152.8K†as of Feb 2022 | 279.2K | — | 68.5K |
| Conterno Enrique ASVP&Pres, LillyDiab & LillyUSA · 50 transactions | — | 138.1K†as of Feb 2019 | 372.2K | — | 175.0K |
| Simmons Jeffrey NSVP&Pres. Elanco Animal Health · 42 transactions | — | 136.6K†as of Feb 2019 | 289.7K | — | 69.1K |
| Armitage Robert ASr. VP and General Counsel · 30 transactions | — | 134.3K†as of Feb 2013 | 229.9K | — | 35.2K |
| O'Neill MylesSVP & Pres., Mfg. Operations · 11 transactions | — | 128.9K†as of Feb 2021 | 70.2K | — | 25.0K |
| Paul Steven MEVP, Science and Technology · 58 transactions | — | 120.3K†as of Feb 2010 | 252.0K | — | 105.5K |
| Murphy Anthony JohnSenior VP, Human Resources · 9 transactions | — | 116.1K†as of Feb 2009 | 41.2K | — | — |
| Crowe Maria APresident, Mfg. Operations · 28 transactions | — | 112.3Kas of Oct 2017 | 154.4K | — | 5.0K |
| Peterson Barton RSr. VP, Corp. Affairs & Comm. · 20 transactions | — | 109.9K†as of Feb 2017 | 134.3K | — | — |
| Carmine Bryce D.EVP and Pres, Lilly Bio-Meds · 43 transactions | — | 109.5K†as of Feb 2012 | 226.2K | — | 73.1K |
| Smiley Joshua LFormer Officer · 12 transactions | — | 79.8K†as of Feb 2021 | 75.2K | 1.5K | 3.0K |
| Seifert Kathi PDirector · 15 transactions | — | 77.0Kas of Nov 2020 | 40.4K | — | — |
| Tapiero JacquesSVP&Pres., Emerging Markets · 24 transactions | — | 76.4K†as of Jan 2014 | 108.8K | — | 46.6K |
| Fyrwald J ErikDirector · 111 transactions | — | 75.4K | 51.2K | 1.6K | — |
| White Anne E.EVP & Pres, Lilly Neuroscience · 20 transactions | — | 74.2Kas of Feb 2025 | 82.7K | 1.0K | 5.0K |
| Horn Karen NDirector · 13 transactions | — | 73.2Kas of Nov 2015 | 32.1K | — | 2.1K |
| Prendergast Franklyn GDirector · 12 transactions | — | 68.6Kas of Nov 2017 | 35.0K | — | — |
| Canute Scott APresident, Mfg. Operations · 12 transactions | — | 67.0K†as of Feb 2007 | 29.0K | — | — |
| Tallarigo LorenzoPresident, Internat'l Opers. · 21 transactions | — | 66.6K†as of Apr 2008 | 65.0K | — | 29.4K |
| Tai Jackson PDirector · 64 transactions | — | 63.5Kas of Apr 2023 | 14.4K | 48.6K | — |
| Zulueta Alfonso GSVP & President, Lilly Int'l · 44 transactions | — | 61.6K†as of Feb 2021 | 229.1K | — | 131.0K |
| Jonsson PatrikEVP & President, LLY Int'l · 18 transactions | — | 61.3K† | 56.7K | — | 7.3K |
| Mahony SusanSVP & Pres., Lilly Oncology · 54 transactions | — | 59.0K†as of Apr 2018 | 269.8K | — | 154.8K |
| Marram Ellen RDirector · 28 transactions | — | 56.6Kas of Apr 2019 | 38.9K | — | — |
| Alvarez RalphDirector · 161 transactions | — | 56.5K† | 45.1K | 758 | — |
| Connelly Deirdre PPresident, Lilly USA · 8 transactions | — | 55.8K†as of Feb 2008 | 61.7K | — | 2.1K |
| Hakim AnatEVP, GC & Secretary · 18 transactions | — | 55.6K† | 73.0K | — | — |
| Gilman Alfred GDirector · 8 transactions | — | 48.3Kas of Nov 2013 | 28.2K | — | — |
| Hernandez EdgardoEVP & Pres., Mfg. Operations · 16 transactions | — | 47.0K† | 36.7K | — | — |
| Eskew Michael LDirector · 14 transactions | — | 45.1Kas of Nov 2021 | 35.6K | — | — |
| Ashkenazi AnatEVP & CFO · 4 transactions | — | 42.5K†as of Feb 2024 | 24.6K | — | — |
| Bischoff Winfried F W SirDirector · 8 transactions | — | 42.4Kas of Nov 2013 | 28.2K | — | — |
| Van Naarden JacobEVP,Pres LLY Oncology&HdCorpBD · 16 transactions | — | 40.6K† | 34.7K | 1.0K | — |
| Mason Michael BEVP & Pres., Lilly Diabetes · 8 transactions | — | 40.2K†as of Feb 2023 | 35.7K | — | — |
| Hoover R DavidDirector · 28 transactions | — | 37.8K†as of Nov 2017 | 30.7K | 500 | — |
| Deane Frank MPresident, Mfg. Operations · 13 transactions | — | 36.5K†as of Feb 2012 | 105.4K | — | 38.4K |
| Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM · 35 transactions | — | 35.5K†as of Feb 2021 | 72.5K | — | 14.7K |
| Shah Aarti S.SVP & CIDO · 11 transactions | — | 34.6K†as of Feb 2021 | 29.9K | — | 3.8K |
| Pusey Leigh AnnEVP, Corp. Affairs & Comm. · 15 transactions | — | 31.6Kas of Feb 2023 | 40.9K | — | — |
| Feldstein Martin SDirector · 6 transactions | — | 30.7Kas of Nov 2011 | 22.2K | — | — |
| Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM · 17 transactions | — | 30.1K†as of Feb 2013 | 28.4K | — | 16.8K |
| Yuffa IlyaEVP&Pres, LLY USA&Global Capab · 17 transactions | — | 29.8K | 34.6K | — | 7.0K |
| Fisher George M CDirector · 31 transactions | — | 28.9Kas of Apr 2008 | 7.6K | — | — |
| Norton JohnaEVP, Global Quality · 30 transactions | — | 27.7K†as of Jun 2024 | 32.7K | — | 15.1K |
| Rau DiogoEVP & CIDO · 12 transactions | — | 26.4K | 38.6K | — | — |
| Hanish Arnold CChief Accounting Officer · 23 transactions | — | 26.2K†as of Oct 2012 | 18.1K | — | 10.2K |
| Baicker KatherineDirector · 14 transactions | — | 23.5K | 20.2K | — | — |
| Oberhelman Douglas RDirector · 6 transactions | — | 22.7Kas of Nov 2014 | 20.3K | — | — |
| Kaelin William G JrDirector · 14 transactions | — | 21.8K | 18.9K | — | — |
| Cook J MichaelDirector · 16 transactions | — | 17.3Kas of Nov 2008 | 12.1K | — | — |
| Luciano Juan RDirector · 97 transactions | — | 16.9K | 15.6K | — | — |
| Runge Marschall SDirector · 12 transactions | — | 16.6Kas of Nov 2023 | 14.7K | 202 | — |
| Montarce LucasEVP & CFO · 7 transactions | — | 16.3K | 5.7K | 715 | — |
| Dozier EricEVP, Chief People Officer · 16 transactions | — | 14.8K† | 16.0K | — | — |
| Custer Kenneth L.EVP & President, Card Met Hlth · 3 transactions | — | 10.2K | 866.28 | — | — |
| Jackson JamereDirector · 11 transactions | — | 9.6K | 8.8K | 200 | — |
| Weems AlonzoEVP, ERM & CECO · 12 transactions | — | 8.0Kas of Feb 2024 | 8.9K | — | 3.5K |
| Walker KarenDirector · 18 transactions | — | 6.2Kas of Nov 2024 | 6.0K | — | — |
| Zakrowski Donald ASVP, Finance, & CAO · 54 transactions | — | 5.3K† | 39.9K | — | 32.4K |
| Brown Adrienne SEVP, President LLY Imm · 3 transactions | — | 5.1K | 1.6K | — | — |
| Azar Alex M IISr. VP, Corp. Affairs & Comm. · 1 transaction | — | 5.0K†as of Jul 2007 | 5.0K | — | — |
| Johnson Kimberly HDirector · 51 transactions | — | 3.3K | 3.2K | — | — |
| Sulzberger GabrielleDirector · 60 transactions | — | 3.0K | 2.8K | 117 | — |
| Hedley Mary LynneDirector · 48 transactions | — | 2.4K† | 2.0K | — | — |
| Bertozzi Carolyn RDirector · 4 transactions | — | 2.0K | 6.1K | — | — |
| Seymour MelissaEVP, Global Quality · 2 transactions | — | 525.08as of Aug 2025 | 952 | — | — |
| Shaw ChristiSVP and Pres., Lilly Bio-Meds · 6 transactions | — | 500as of May 2019 | 27.5K | — | 15.5K |
| Moeller Jon RDirector · 1 transaction | — | 304.27 | 233.27 | — | — |